Since NKG2D plays a major role in the recognition of CMV infected cells (highlighted by the many proteins CMV expresses to temper NKG2D ligand expression41), the downregulation of NKG2D on CLL-derived NK cells might have significant consequences for NK cell responses towards CMV in CLL. The gene discussed is KLRK1; the disease is B-cell chronic lymphocytic leukemia.